Dynamic behaviors of vimentin induced by interaction with GlcNAc molecules

Glycobiology

Volumn 22, Issue 12, 2012, Pages 1741-1759

  Komura, Kenta ^a   Ise, Hirohiko ^a   Akaike, Toshihiro ^a  

^a TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

cancer cells; N acetylglucosamine; O GlcNAc protein; vimentin

Indexed keywords

N ACETYLGLUCOSAMINE; POLYMER; PROTEIN KINASE C; RHO KINASE; SERINE; TETRAMER; VIMENTIN;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL DEATH; CELL MIGRATION; CELL SURFACE; CULTURE MEDIUM; FEMALE; HELA CELL; HUMAN; HUMAN CELL; KIDNEY CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN CARBOHYDRATE INTERACTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

ACETYLGLUCOSAMINE; ANIMALS; CELL DEATH; CELL MOVEMENT; DOGS; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; MADIN DARBY CANINE KIDNEY CELLS; MEMBRANE GLYCOPROTEINS; MUTATION, MISSENSE; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN MULTIMERIZATION; SERINE; VIMENTIN;

EID: 84868516770     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cws118     Document Type: Article

References (39)

1. Ando S, Tanabe K, Gonda Y, Sato C, Inagaki M. 1989. Domain-and sequence-specific phosphorylation of vimentin induces disassembly of the filament structure. Biochemistry. 28:2974-2979.
2. Aso S, Ise H, Takahashi M, Kobayashi S, Morimoto H, Izawa A, Goto M, Ikeda U. 2007. Effective uptake of N-acetylglucosamine-conjugated liposomes by cardiomyocytes in vitro. J Control Release. 122:189-198.
3. Bae SN, Arand G, Azzam H, Pavasant P, Torri J, Frandsen TL, Thompson EW. 1993. Molecular and cellular analysis of basement membrane invasion by human breast cancer cells in Matrigel-based in vitro assays. Breast Cancer Res Treat. 24:241-255.
4. Ben-Ze'ev A, Raz A. 1985. Relationship between the organization and synthesis of vimentin and the metastatic capability of B16 melanoma cells. Cancer Res. 45:2632-2641.
5. Caselitz J, Jänner M, Breitbart E, Weber K, Osborn M. 1983. Malignant melanomas contain only the vimentin type of intermediate filaments. Virchows Arch A Pathol Anat Histopathol. 400:43-51.
6. Colucci-Guyon E, Portier MM, Dunia I, Paulin D, Pournin S, Babinet C. 1994. Mice lacking vimentin develop and reproduce without an obvious phenotype. Cell. 79:679-694.
7. Cufí S, Vazquez-Martin A, Oliveras-Ferraros C, Martin-Castillo B, Joven J, Menendez JA. 2010. Metformin against TGFβ-induced epithelial-tomesenchymal transition (EMT): From cancer stem cells to aging-associated fibrosis. Cell Cycle. 9:4461-4468.
8. Cutrera J, Dibra D, Xia X, Hasan A, Reed S, Li S. 2011. Discovery of a linear peptide for improving tumor targeting of gene products and treatment of distal tumors by IL-12 gene therapy. Mol Ther. 19:1468-1477.
9. Eriksson JE, He T, Trejo-Skalli AV, Härmälä-Braskén AS, Hellman J, Chou YH, Goldman RD. 2004. Specific in vivo phosphorylation sites determine the assembly dynamics of vimentin intermediate filaments. J Cell Sci. 117:919-932.
10. Fukasawa Y, Ishikura H, Takada A, Yokoyama S, Imamura M, Yoshiki T, Sato H. 1994. Massive apoptosis in infantile myofibromatosis. A putative mechanism of tumor regression. Am J Pathol. 144:480-485.
11. Gabbiani G, Kapanci Y, Barazzone P, Franke WW. 1981. Immunochemical identification of intermediate-sized filaments in human neoplastic cells. A diagnostic aid for the surgical pathologist. Am J Pathol. 104:206-216.
12. Gabbiani G, Rungger-Brändle E, De Chastonay C, Franke WW. 1982. Vimentin-containing smooth muscle cells in aortic intimal thickening after endothelial injury. Lab Invest. 47:265-269.
13. Gilles C, Polette M, Birembaut P, Brünner N, Thompson EW. 1997. Expression of c-ets-1 mRNA is associated with an invasive, EMT-derived phenotype in breast carcinoma cell lines. Clin Exp Metastasis. 15:519-526.
14. Gilles C, Polette M, Zahm JM, Tournier JM, Volders L, Foidart JM, Birembaut P. 1999. Vimentin contributes to human mammary epithelial cell migration. J Cell Sci. 112:4615-4625.
15. Gonzales M, Weksler B, Tsuruta D, Goldman RD, Yoon KJ, Hopkinson SB, Flitney FW, Jones JC. 2001. Structure and function of a vimentin-associated matrix adhesion in endothelial cells. Mol Biol Cell. 12:85-100.
16. Goto H, Kosako H, Tanabe K, Yanagida M, Sakurai M, Amano M, Kaibuchi K, Inagaki M. 1998. Phosphorylation of vimentin by Rho-associated kinase at a unique amino-terminal site that is specifically phosphorylated during cytokinesis. J Biol Chem. 273:11728-11736.
17. Grille SJ, Bellacosa A, Upson J, Klein-Szanto AJ, van Roy F, Lee-Kwon W, Donowitz M, Tsichlis PN, Larue L. 2003. The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res. 63:2172-2178.
18. Helfand BT, Mendez MG, Murthy SN, Shumaker DK, Grin B, Mahammad S, Aebi U, Wedig T, Wu YI, Hahn KM et al. 2011. Vimentin organization modulates the formation of lamellipodia. Mol Biol Cell. 22:1274-1289.
19. Homan SM, Mercurio AM, LaFlamme SE. 1998. Endothelial cells assemble two distinct α6β4-containing vimentin-associated structures: Roles for ligand binding and the beta4 cytoplasmic tail. J Cell Sci. 111:2717-2728.
20. Hu L, Lau SH, Tzang CH, Wen JM, Wang W, Xie D, Huang M, Wang Y, Wu MC, Huang JF et al. 2004. Association of Vimentin overexpression and hepatocellular carcinoma metastasis. Oncogene. 23:298-302.
21. Ise H, Goto M, Komura K, Akaike T. 2012. Engulfment and clearance of apoptotic cells based on a GlcNAc-binding lectin-like property of surface vimentin. Glycobiology. 22:788-805.
22. Ise M, Ise H, Shiba Y, Kobayashi S, Goto M, Takahashi M, Akaike T, Ikeda U. 2011. Targeting N-acetylglucosamine-bearing polymer-coated liposomes to vascular smooth muscle cells. J Artif Organs. 14:301-309.
23. Ise H, Kobayashi S, Goto M, Sato T, Kawakubo M, Takahashi M, Ikeda U, Akaike T. 2010. Vimentin and desmin possess GlcNAc-binding lectin-like properties on cell surfaces. Glycobiology. 20:843-864.
24. Izawa I, Inagaki M. 2006. Regulatory mechanisms and functions of intermediate filaments: A study using site-and phosphorylation state-specific antibodies. Cancer Sci. 97:167-174.
25. Kim SJ, Ise H, Goto M, Komura K, Cho CS, Akaike T. 2011. Gene delivery system based on highly specific recognition of surface-vimentin with N-acetylglucosamine immobilized polyethylenimine. Biomaterials. 32:3471-3480.
26. Korsching E, Packeisen J, Liedtke C, Hungermann D, Wülfing P, van Diest PJ, Brandt B, Boecker W, Buerger H. 2005. The origin of vimentin expression in invasive breast cancer: Epithelial-mesenchymal transition, myoepithelial histogenesis or histogenesis from progenitor cells with bilinear differentiation potential? J Pathol. 206:451-457.
27. Kreis S, Schönfeld HJ, Melchior C, Steiner B, Kieffer N. 2005. The intermediate filament protein vimentin binds specifically to a recombinant integrin alpha2/beta1 cytoplasmic tail complex and co-localizes with native alpha2/beta1 in endothelial cell focal adhesions. Exp Cell Res. 305:110-121.
28. Langa F, Kress C, Colucci-Guyon E, Khun H, Vandormael-Pournin S, Huerre M, Babinet C. 2000. Teratocarcinomas induced by embryonic stem (ES) cells lacking vimentin: An approach to study the role of vimentin in tumorigenesis. J Cell Sci. 113:3463-3472.
29. Lundgren K, Nordenskjöld B, Landberg G. 2009. Hypoxia, Snail and incomplete epithelial-mesenchymal transition in breast cancer. Br J Cancer. 101:1769-1781.
30. Mor-Vaknin N, Punturieri A, Sitwala K, Markovitz DM. 2003. Vimentin is secreted by activated macrophages. Nat Cell Biol. 5:59-63.
31. Nishimura N, Balch WE. 1997. A di-acidic signal required for selective export from the endoplasmic reticulum. Science. 277:556-558.
32. Perides G, Harter C, Traub P. 1987. Electrostatic and hydrophobic interactions of the intermediate filament protein vimentin and its amino terminus with lipid bilayers. J Biol Chem. 262:13742-13749.
33. Sommers CL, Heckford SE, Skerker JM, Worland P, Torri JA, Thompson EW, Byers SW, Gelmann EP. 1992. Loss of epithelial markers and acquisition of vimentin expression in adriamycin-and vinblastine-resistant human breast cancer cell lines. Cancer Res. 52:5190-5197.
34. Steinmetz NF, Cho CF, Ablack A, Lewis JD, Manchester M. 2011. Cowpea mosaic virus nanoparticles target surface vimentin on cancer cells. Nanomedicine (Lond). 6:351-364.
35. Trog D, Yeghiazaryan K, Schild HH, Golubnitschaja O. 2008. Up-regulation of vimentin expression in low-density malignant glioma cells as immediate and late effects under irradiation and temozolomide treatment. Amino Acids. 34:539-545.
36. Tsuruta D, Jones JC. 2003. The vimentin cytoskeleton regulates focal contact size and adhesion of endothelial cells subjected to shear stress. J Cell Sci. 116:4977-4984.
37. Valentijn AJ, Upton JP, Gilmore AP. 2008. Analysis of endogenous Bax complexes during apoptosis using blue native PAGE: Implications for Bax activation and oligomerization. Biochem J. 412:347-357.
38. Vuoriluoto K, Haugen H, Kiviluoto S, Mpindi JP, Nevo J, Gjerdrum C, Tiron C, Lorens JB, Ivaska J. 2011. Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer. Oncogene. 30:1436-1448.
39. Yokoyama K, Kamata N, Fujimoto R, Tsutsumi S, Tomonari M, Taki M, Hosokawa H, Nagayama M. 2003. Increased invasion and matrix met alloproteinase-2 expression by Snail-induced mesenchymal transition in squamous cell carcinomas. Int J Oncol. 22:891-898.